S. Shalaev

发表

EURASIAN CLINICAL GUIDELINES ON DIAGNOSIS AND TREATMENT OF PULMONARY HYPERTENSION

O. Barbarash, I. Chazova, O. Stukalova, 2020 .

THE SPECIFICS OF HYPERTENSION PREVALENCE IN TYUMENSKAYA REGION AND ITS TREATMENT EFFICACY AMONG INHABITANTS OF 25-64 YEAR OLD

I. Medvedeva, S. Shalaev, A. Efanov, 2017 .

Cardiorenal syndrome in the early stages of coronary bypass surgery.

S. Shalaev, A. Efanov, L. V. Kremneva, 2018, Terapevticheskii arkhiv.

[The importance of modern high - sensitivity troponin tests in the diagnosis of myocardial infarction without ST-segment elevation].

S. Shalaev, L. V. Kremneva, S. Suplotov, 2019, Terapevticheskii arkhiv.

EXPERIENCE OF IDIOPATHIC PULMONARY ARTERIAL HYPERTENSION PATIENTS MANAGEMENT IN URAL FEDERAL DISTRICT: FEATURES OFOUTPATIENT-HOSPITAL INTERACTIONS

S. Shalaev, M. Arkhipov, A. L. Iofin, 2019, Eurasian heart journal.

Place of Prasugrel, P2Y12 receptor antagonist, in an early invasive treatment of patients with acute coronary syndrome (according to the results of multicenter randomized controlled trial ISAR-REACT 5)

S. A. Ustyugov, D. Duplyakov, O. Averkov, 2019, Russian Journal of Cardiology.

[Duration and Timing of Initiation of Therapy With Platelet P2Y12 Inhibitors in the Treatment of Patients With Acute Coronary Syndrome].

S. Shalaev, Z. Safiullina, 2018, Kardiologiia.

Persistent dyslipidemia in statin-treated patients: Russian real-world clinical practice data (Russian part of the DYSIS Study)

S. Martsevich, Y. Karpov, R. Oganov, 2012 .

EURASIAN ASSOCIATION OF CARDIOLOGY (EAC) GUIDELINES FOR THE DIAGNOSIS AND TREATMENT OF CHRONIC THROMBOEMBOLIC PULMONARY HYPERTENSION (2020)

R. Akchurin, I. Chazova, O. Stukalova, 2021, Eurasian heart journal.

Markers of vascular damage depending on the blood pressure level: data of the population study ESSE-RF

A. Deev, S. Shalnova, S. Boytsov, 2020, Russian Journal of Cardiology.

The Modern Method of Creating Dynamically Scaled Models to Study Aircraft Flutter Characteristics

I. V. Markin, A. V. Dolgopolov, S. Shalaev, 2020, Uchenye Zapiski Kazanskogo Universiteta. Seriya Fiziko-Matematicheskie Nauki.

Eurasian guidelines for the diagnosis and treatment of pulmonary hypertension associated with congenital heart defects in adults (2021)

I. Chazova, O. Stukalova, T. Martynyuk, 2022, Eurasian heart journal.

N-acetylcysteine in the Prevention of Contrast-induced Acute Kidney Injury: a Systematic Review and Meta-analysis of Randomized Controlled Clinical Trials

S. Shalaev, E. Mezhonov, Y. A. Vyalkina, 2022, Rational Pharmacotherapy in Cardiology.

Нospital outcomes of coronary artery bypass grafting in patients with coronary heart disease with previous percutaneous coronary intervention

S. Shalaev, S. Suplotov, Lyudmila V. Kremneva, 2022, Terapevticheskii arkhiv.

Cardiorenal syndrome in the early stages of coronary bypass surgery

S. Shalaev, A. Efanov, L. V. Kremneva, 2018, Terapevticheskii arkhiv.

[Prognostic value of acute cardiorenal syndrome in patients with acute cardiac pathology].

S. Shalaev, E. Mezhonov, Ju. A. Vyalkina, 2019, Kardiologiia.

[Effects of lovastatin (mevacor) on platelet function in hypercholesterolemia in patients with ischemic heart disease].

S. Shalaev, Z. Safiullina, T. Baranova, 1992, Kardiologiia.

2020 Clinical practice guidelines for Pulmonary hypertension, including chronic thromboembolic pulmonary hypertension

O. Barbarash, I. Chazova, O. Stukalova, 2021, Russian Journal of Cardiology.

SPECIFICS OF ANTIHYPERTENSION THERAPY IN HYPERTENSIVES OF VARIOUS CARDIOVASCULAR RISK (BY THE REGISTRY OF CHRONIC NON-COMMUNICABLE DISEASES IN TYUMENSKAYA OBLAST)

S. Shalaev, A. Efanov, O. Abaturova, 2018, Cardiovascular Therapy and Prevention.

2020 Clinical practice guidelines for Acute coronary syndrome without ST segment elevation

S. A. Ustyugov, N. Pogosova, D. Duplyakov, 2022, Russian Journal of Cardiology.

ARTERIAL HYPERTENSION AMONG INDIVIDUALS OF 25–64 YEARS OLD: PREVALENCE, AWARENESS, TREATMENT AND CONTROL. BY THE DATA FROM ECCD

N. I. Babenko, A. Deev, S. Shalnova, 2014 .

[Predictors of acute heart failure in patients with ST-segment elevation myocardial infarction of the electrocardiogram after PCI].

S. Shalaev, E. Mezhonov, Y. A. Vyalkina, 2018, Kardiologiia.

THE FEATURES OF ANTIHYPERTENSIVE THERAPY IN PATIENTS WITH METABOLIC SYNDROME

S. Shalaev, L. V. Kremneva, O. Abaturova, 2014 .

Relationship of depressive disorders with hypertension, its control and other metabolic risk factors in the Tyumen Oblast population of men and women. Data from the study “Epidemiology of Cardiovascular Diseases and their Risk Factors in Regions of Russian Federation” (ESSE-RF)

S. Shalaev, A. Efanov, I. Sholomov, 2022, Russian Journal of Cardiology.

[N-terminal fragment of the brain natriuretic peptide and proinflammatory cytokines in patients with ischemic heart disease].

S. Shalaev, S. I. Volkova, 2009, Terapevticheskii arkhiv.

[Influence of Loading Dose Of Atorvastatin on the Risk of Contrast-Induced Nephropathy in Patients With ST-Segment Elevation Myocardial Infarction].

S. Shalaev, A. A. Shermuk, E. Mezhonov, 2023, Kardiologiia.

[Phosphocreatine: thrombocyte aggregation in patients with stenocardia].

M. Giorgadze, S. Shalaev, E. Panchenko, 1987, Biulleten' Vsesoiuznogo kardiologicheskogo nauchnogo tsentra AMN SSSR.

Acute kidney injury as a risk factor for atrial fibrillation after coronary artery bypass grafting — effects of sodium-glucose cotransporter-2 inhibitors

S. Shalaev, L. V. Kremneva, S. Suplotov, 2023, Rational Pharmacotherapy in Cardiology.

Nephroprotective effect of atorvastatin at a dose of 80 mg in patients with ST-segment elevation myocardial infarction with an invasive treatment strategy

S. Shalaev, E. Mezhonov, D. V. Krasheninin, 2023, Rational Pharmacotherapy in Cardiology.